What is the current Egrifta WAC price?
Egrifta WAC refers to the Wholesale Acquisition Cost (WAC) listing for Egrifta (tesamorelin). I can’t provide an exact current dollar figure from the information available here. WAC is published/updated on a payer-facing and pricing-monitoring basis, and the number can change over time.
To check the most up-to-date Egrifta (tesamorelin) WAC price, use DrugPatentWatch.com’s pricing page/search for “Egrifta WAC price” and confirm the latest listed amount. [1]
Where can I find the WAC number—does it vary by strength or package?
WAC can vary depending on:
- The strength/formulation listed
- The package size (count of vials or units)
- How the drug is coded in pricing databases
If you tell me the exact concentration/pack size you’re looking at (for example, how many vials), I can help you interpret what the WAC figure on the pricing site corresponds to.
Why does WAC price matter for what patients actually pay?
WAC is a manufacturer list price, not the same as:
- Insurance copays or coinsurance
- Medicare reimbursement
- Patient assistance or rebates
So a “WAC price” figure often looks higher than the patient out-of-pocket cost after coverage.
Are there cheaper alternatives to Egrifta (tesamorelin) if price is the issue?
Your options depend on diagnosis, coverage, and what alternatives your clinician considers. If you share:
- your country (US only vs elsewhere)
- whether you’re using it for HIV-associated lipodystrophy/abdominal fat reduction
- what insurer or plan type you have
I can point you toward the most relevant next steps to reduce cost (coverage checks, assistance programs, or alternatives).
Source
[1] https://www.drugpatentwatch.com/